Sunmax Biotechnology , Ltd. Total Liabilities

Sunmax Biotechnology , Ltd. (4728.TWO) currently reports a total liabilities of $570M as of June 2026. That compares with $1.1B in the prior-year period — down 50.2% year over year. Use the charts on this page to explore Sunmax Biotechnology , Ltd.'s total liabilities history and peer comparisons.

Sunmax Biotechnology , Ltd.'s total liabilities decreased from $1.1B to $570M — a 50.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sunmax Biotechnology , Ltd. reported $570M in total liabilities as of June 2026. That compares with $1.1B in the prior-year period — down 50.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $570M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sunmax Biotechnology , Ltd., and consider following 4728.TWO for alerts when major investors trade the stock.

Sunmax Biotechnology , Ltd. is classified in the Healthcare sector. On total liabilities, it currently shows $570M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 4728.TWO with unrelated industries.